Pablo H. Montero
Santiago, RM, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Intermediate-Risk Papillary Thyroid Cancer: Not Everyone Needs Radioactive Iodine.
Journal: Clinical endocrinology
Published: March 30, 2026
ThyroidPrint: Thyroid Genetic Classifier Long-Term Follow-Up of Benign Called Lesions.
Journal: Clinical endocrinology
Published: December 17, 2025
Melanoma in Chile: demographics and clinico-pathological features.
Journal: Frontiers in oncology
Published: April 01, 2025
Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
Journal: Archives of endocrinology and metabolism
Published: May 06, 2024
Latin American Consensus on the Treatment of Head and Neck Cancer.
Journal: JCO global oncology
Published: April 11, 2024
Lobectomy in patients with differentiated thyroid cancer: experience of a Chilean tertiary center.
Journal: Endocrine
Published: March 28, 2024
ThyroidPrint®: clinical utility for indeterminate thyroid cytology.
Journal: Endocrine-related cancer
Published: December 25, 2022
Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-centre cohort study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 30, 2021
Warthin-like and classic papillary thyroid cancer have similar clinical presentation and prognosis.
Journal: Archives of endocrinology and metabolism
Published: May 25, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026